Another study investigated a MAGEA3 and HPV16 trojan vaccine in HNSCC and could detect antigen-specific TILs and peripheral T cells with no effect on the clinical outcome of the patients (NCT00257738, Table 1, see also CTAs section) [67]. The gene discussed is MAGEA3; the disease is head and neck squamous cell carcinoma.